These cells differentiate into TAMs, tumor-associated dendritic cells (TADCs), and tumor-associated neutrophils (TANs), which protect tumor cells from immune surveillance by inhibiting natural killer (NK) cells and CD8+ T cells [17]. This evidence concerns the gene CD8A and neoplasm.